RVMD Sale Disclosure
Kim Lorence H. · SEC Form 4 · Filed Sep 2, 2026
Sale
Calculated transaction value
$2.62M
Kim Lorence H. Director
RVMD
Revolution Medicines
RVMD
Transaction date
Aug 31, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 2 days later
RVMD daily price context
Close on/before transaction
$205.57
Aug 31, 2026
Close before public filing
$209.87
Sep 1, 2026
Return since public filing
-9.22%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,919 shares @ $202.48
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-380277
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$11.38M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Revolution Medicines, Inc. RVMD | Sale | Aug 31, 2026 | $60.17K |
| Revolution Medicines, Inc. RVMD | Sale | Aug 31, 2026 | $1.33M |
| Revolution Medicines, Inc. RVMD Current | Sale | Aug 31, 2026 | $2.62M |
| Revolution Medicines, Inc. RVMD | Sale | Aug 31, 2026 | $5.32M |
| Revolution Medicines, Inc. RVMD | Sale | Aug 31, 2026 | $1.49M |
| Revolution Medicines, Inc. RVMD | Sale | Aug 31, 2026 | $436.64K |
| Revolution Medicines, Inc. RVMD | Sale | Aug 31, 2026 | $128.85K |